News
MGC Pharmaceuticals (ASX: MXC) has changed its name to Argent Biopharma - RGT (ASX: RGT).
Below are the previous articles from MGC Pharmaceuticals (ASX: MXC):
RELATED STOCKHEAD STORIES
News
Rise and Shine: What you need to know before the ASX opens
Health & Biotech
Going viral: All the biggest COVID-19 news from the last week
Health & Biotech
MGC Pharma stock surges 60pc after launching COVID-19 study
Health & Biotech
MGC Pharma drives home Brazil advantage with lucrative seven-year supply agreement
Health & Biotech
Cannabis: Impression Healthcare is testing its cannabinoid formula against brain injuries
Health & Biotech
Australia is a leader in cannabis biotechs – here are three stocks that could be poised for growth
Health & Biotech
Sales of MGCs new low-cost Mercury Pharma line are surging higher
Health & Biotech
MGC Pharma announces $4m capital raise backed by new cornerstone investor
News
Rise and Shine: What you need to know before the ASX opens
Health & Biotech
MGC Pharma has turned potential into momentum in Q2
Health & Biotech
Next stop, Peru: MGC Pharma is getting ahead of the game in the huge South American market
Health & Biotech
MGC Pharma scores revenue boost with strategic distribution deal for the Australian market
Health & Biotech
MGC takes aim at medical cannabis affordability with new line of products
Experts
Money Talks: These 3 pot stocks could profit as regulatory roadblocks crumble in 2020
Health & Biotech
MGC starts European grand tour in Ireland
Health & Biotech
MGC hits a landmark deal with key strategic partnership to launch into Latin America
News